Occupational exposure to glyphosate and risk of lymphoma:results of an Italian multicenter case-control study.


Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 02 11 2020
accepted: 14 04 2021
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 19 8 2021
Statut: epublish

Résumé

The International Agency for Research on Cancer (IARC) recently classified glyphosate, the most used herbicide worldwide, as a probable human carcinogen. We inquired into the association between occupational exposure to glyphosate and risk of lymphoma subtypes in a multicenter case-control study conducted in Italy. The Italian Gene-Environment Interactions in Lymphoma Etiology (ItGxE) study took place in 2011-17 in six Italian centres. Overall, 867 incident lymphoma cases and 774 controls participated in the study. Based on detailed questionnaire information, occupational experts classified duration, confidence, frequency, and intensity of exposure to glyphosate for each study subject. Using unconditional regression analysis, we modelled risk of major lymphoma subtypes associated with exposure to glyphosate adjusted by age, gender, education, and study centre. Very few study subjects (2.2%) were classified as ever exposed to glyphosate. Risk of follicular lymphoma (FL) was elevated 7-fold in subjects classified as ever exposed to glyphosate with medium-high confidence, 4.5-fold in association with medium-high cumulative exposure level, 12-fold with medium-high exposure intensity, and 6-fold with exposure for 10 days or more per year. Significant upward trends were detected with all the exposure metrics, but duration. The overall p-value for an upward trend with four independent metrics was 1.88 × 10 Our findings provide limited support to the IARC decision to classify glyphosate as Group 2A human carcinogen.

Sections du résumé

BACKGROUND
The International Agency for Research on Cancer (IARC) recently classified glyphosate, the most used herbicide worldwide, as a probable human carcinogen. We inquired into the association between occupational exposure to glyphosate and risk of lymphoma subtypes in a multicenter case-control study conducted in Italy.
METHODS
The Italian Gene-Environment Interactions in Lymphoma Etiology (ItGxE) study took place in 2011-17 in six Italian centres. Overall, 867 incident lymphoma cases and 774 controls participated in the study. Based on detailed questionnaire information, occupational experts classified duration, confidence, frequency, and intensity of exposure to glyphosate for each study subject. Using unconditional regression analysis, we modelled risk of major lymphoma subtypes associated with exposure to glyphosate adjusted by age, gender, education, and study centre.
RESULTS
Very few study subjects (2.2%) were classified as ever exposed to glyphosate. Risk of follicular lymphoma (FL) was elevated 7-fold in subjects classified as ever exposed to glyphosate with medium-high confidence, 4.5-fold in association with medium-high cumulative exposure level, 12-fold with medium-high exposure intensity, and 6-fold with exposure for 10 days or more per year. Significant upward trends were detected with all the exposure metrics, but duration. The overall p-value for an upward trend with four independent metrics was 1.88 × 10
CONCLUSIONS
Our findings provide limited support to the IARC decision to classify glyphosate as Group 2A human carcinogen.

Identifiants

pubmed: 33910586
doi: 10.1186/s12940-021-00729-8
pii: 10.1186/s12940-021-00729-8
pmc: PMC8082925
doi:

Substances chimiques

Herbicides 0
Glycine TE7660XO1C

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

49

Références

Pest Manag Sci. 2018 May;74(5):1027-1034
pubmed: 28643882
Environ Health Perspect. 2005 Jan;113(1):49-54
pubmed: 15626647
Arch Toxicol. 2017 Aug;91(8):2723-2743
pubmed: 28374158
Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1155-63
pubmed: 11700263
Cancer Res. 1992 May 1;52(9):2447-55
pubmed: 1568215
Mutat Res. 2019 Jul - Sep;781:186-206
pubmed: 31342895
Int J Cancer. 2006 Aug 15;119(4):901-8
pubmed: 16557575
Int J Environ Res Public Health. 2014 Apr 23;11(4):4449-527
pubmed: 24762670
Scand J Work Environ Health. 2019 Nov 1;45(6):600-609
pubmed: 31246262
Occup Environ Med. 2013 Feb;70(2):91-8
pubmed: 23117219
Int J Epidemiol. 1993;22 Suppl 2:S42-5
pubmed: 8132391
Int J Epidemiol. 2019 Oct 1;48(5):1519-1535
pubmed: 30880337
J Agromedicine. 2012 Jan;17(1):30-9
pubmed: 22191501
Int J Cancer. 2013 Oct 15;133(8):1846-58
pubmed: 23564249
Cancer Causes Control. 1993 Mar;4(2):153-6
pubmed: 8481493
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):130-44
pubmed: 25174034
Blood. 2009 Jun 18;113(25):6386-91
pubmed: 19387005
Int J Cancer. 2008 Oct 1;123(7):1657-63
pubmed: 18623080
Occup Environ Med. 2009 May;66(5):291-8
pubmed: 19017688
Cancer. 1999 Mar 15;85(6):1353-60
pubmed: 10189142
Environ Sci Eur. 2016;28(1):3
pubmed: 27752438
Occup Environ Med. 2003 Sep;60(9):E11
pubmed: 12937207
Br J Cancer. 1998 Jun;77(11):2048-52
pubmed: 9667691
Am J Ind Med. 2003 Dec;44(6):627-36
pubmed: 14635239
Blood. 2011 May 12;117(19):5019-32
pubmed: 21300984
Appl Occup Environ Hyg. 2001 Feb;16(2):246-50
pubmed: 11217718

Auteurs

Federico Meloni (F)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. federicomeloni@hotmail.it.

Giannina Satta (G)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Marina Padoan (M)

Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, Novara, Italy.

Andrea Montagna (A)

Department of Medicine and Surgery, Occupational Medicine, Respiratory Diseases and Toxicology Section, University of Perugia, Perugia, Italy.

Ilaria Pilia (I)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Alessandra Argiolas (A)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Sara Piro (S)

Environmental and Occupational Epidemiology Branch - Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Corrado Magnani (C)

Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, Novara, Italy.

Angela Gambelunghe (A)

Department of Medicine and Surgery, Occupational Medicine, Respiratory Diseases and Toxicology Section, University of Perugia, Perugia, Italy.

Giacomo Muzi (G)

Department of Medicine and Surgery, Occupational Medicine, Respiratory Diseases and Toxicology Section, University of Perugia, Perugia, Italy.

Giovanni Maria Ferri (GM)

Interdisciplinary Department of Medicine (DIM), Unit of Occupational Medicine, University of Bari, Bari, Italy.

Luigi Vimercati (L)

Interdisciplinary Department of Medicine (DIM), Unit of Occupational Medicine, University of Bari, Bari, Italy.

Roberta Zanotti (R)

Department of Medicine, Haematology Unit, and Department of Diagnostics and Public Health-Section of Pathology, Verona University Hospital, Verona, Italy.

Aldo Scarpa (A)

Department of Medicine, Haematology Unit, and Department of Diagnostics and Public Health-Section of Pathology, Verona University Hospital, Verona, Italy.

Mariagrazia Zucca (M)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Sara De Matteis (S)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Marcello Campagna (M)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Lucia Miligi (L)

Environmental and Occupational Epidemiology Branch - Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Pierluigi Cocco (P)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH